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Stellingen behorende bij het proefschrift 
“CRISPR/Cas9 genetic modification of Plasmodium falciparum and transgenic parasites in malaria vaccine 
research” 
1. Transgenic Plasmodium falciparum reporter lines, expressing fluorescent and luminescent reporter 
proteins are not only being used to study the basic biology of malaria parasites but are now also being 
used as valuable tools to rapidly evaluate novel vaccines and vaccination strategies (this thesis). 
 
2. Optimizing CRISPR/Cas9 technologies to edit the P. falciparum genome without the retention of drug-
resistance genes in the parasite genome, greatly simplifies the production of parasites with multiple 
genetic modifications and thereby enhances their development as novel vaccines (this thesis). 
 
3. The circumsporozoite protein (CSP) of the human malaria parasites, P. falciparum and P. vivax, can 
replace and complement the function of rodent malaria parasite CSP. However, the inability to create 
viable sporozoites after replacement of P. falciparum CSP with P. vivax CSP is unexpected and shows 
that full sporozoite maturation in P. falciparum is likely dependent on species-specific features of CSP 
(this thesis). 
 
4. Although the processes of gamete formation, fertilization and zygote development are highly similar 
between rodent and human malaria parasites, critical differences exists in the function of several 
orthologous fertilization proteins of human and rodent parasites. This has implications of modelling 
and evaluating transmission blocking vaccines, in vivo, using rodent models of malaria (this thesis). 
 
5. Despite the efficiency and flexibility of CRISPR/Cas9 methods to genetically modify multiple genomes, 
‘off-target’ DNA breaks can often be introduced by single guide RNA/Cas9 expression, as has been 
demonstrated in mouse embryonic cells. Consequently, such unintended genomic damage caused by 
CRISPR-Cas9 editing may have pathogenic consequences in therapies that utilize this method to 
genetically repair deleterious mutations in humans (Kosicki, M. et. al. Nature Biotechnology, 2018). 
 
6. While most research on human microbes is dedicated to their elimination, infectious organisms are 
now increasingly being seen as potential therapeutic agents, which have a large potential to play a 
role in the treatment of different diseases (Lukasiewicz, K. et. al. Journal of Immunology Research, 
2018). 
 
7. Mice often respond to experimental interventions in ways that differ strikingly from humans; 
therefore the use of mice in biomedical research needs to take into account the evolved differences 
in response to infection and disease as well as the physiological similarities of these hosts (Perlman, 
R.L. Evolution, Medicine and Public Health, 2016). 
 
8. In debates about the nature of the disease caused by vector borne infections that can cross the 
placental barrier, such as Zika, it is important to take into account the possible long-term effects that 
may arise in the children years after infection of the mother (Zika Virus and Birth Defects — Reviewing 
the Evidence for Causality; NEJM Special Report 2016). 
 
9. Unlike other mammals, hominids during their evolution lost their ability to synthesize the 
carbohydrate α-Gal, resulting in the ability to generate high antibody titters against α-Gal. This 
process may have conferred an advantage against a number of vector borne disease; however, 
despite this ability 17% of all infections of humans worldwide are vector borne diseases (Cruz, Valdes 
and de la Fuente (2016) Expert review of Vaccines).  
 
10. “If curiosity and wonder are childlike, then so be it. When I think of science and scientists I think of 
kids who never lost their curiosity and wonder and then woke up one day as adults with the very 
same sense of search for what is and what is not true in the world.” (Neil de Grasse Tyson in interview 
with Arianna Huffington 2017; Thrive Global ). Curiosity and the ability to wonder about simple things 
is the central basis of science. 
 
11. It does not take much strength to do things, but it requires a great deal of strength to decide what to 
do (Elbert Hubbard 1856-1915). Spending time end energy for making decisions on what to do is 
important for reaching your goals.  
 
12. When you find your path, you must not be afraid. You need to have sufficient courage to make 
mistakes. Disappointment, defeat, and despair are the tools that God uses to show us the way (Paulo 
Coelho, Brida, 1990). Mistakes, defeat and despair are the best teachers, they give an opportunity to 
learn and to start over better prepared. 
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